Table 5.
Biochemical parameters of the participants (n 187)
| OST (n 97) | Rehabilitation (n 90) | P-value | Total (n 187) | ||||
|---|---|---|---|---|---|---|---|
| Mean | sd | Mean | sd | Mean | sd | ||
| Erythrocyte (cells/mcl) | 5⋅2 | 0⋅5 | 5⋅2 | 0⋅4 | 0⋅229 | 5⋅2 | 0⋅4 |
| Hgb (g/dl) | 14⋅7 | 1⋅5 | 15⋅0 | 1⋅2 | 0⋅127‡ | 14⋅8 | 1⋅3 |
| Hct (%) | 43⋅6 | 3⋅7 | 44⋅5 | 2⋅9 | 0⋅085* | 44⋅0 | 3⋅4 |
| Leucocyte (cells/mcl) | 8⋅5 | 2⋅5 | 7⋅2 | 2⋅1 | 0⋅001* | 7⋅9 | 2⋅4 |
| Platelet (cells/mcl) | 259⋅8 | 63⋅5 | 249⋅2 | 66⋅2 | 0⋅291 | 254⋅4 | 64⋅9 |
| Total Proteins (g/dl) | 7⋅4 | 0⋅4 | 7⋅3 | 0⋅4 | 0⋅008*† | 7⋅3 | 0⋅4 |
| Albumin (g/dl) | 4⋅3 | 0⋅2 | 4⋅2 | 0⋅3 | 0⋅135 | 4⋅3 | 0⋅3 |
| FBS (mg/dl) | 94⋅2 | 16⋅8 | 85⋅4 | 7⋅4 | <0⋅001* | 89⋅7 | 13⋅6 |
| Total cholesterol (mg/dl) | 188⋅8 | 53⋅4 | 190⋅9 | 39⋅8 | 0⋅773 | 189⋅9 | 46⋅9 |
| LDL (mg/dl) | 115⋅1 | 44⋅3 | 115⋅9 | 33⋅1 | 0⋅891 | 115⋅5 | 38⋅9 |
| HDL (mg/dl) | 43⋅3 | 12⋅3 | 44⋅3 | 12⋅5 | 0⋅339 | 43⋅8 | 12⋅3 |
| Males | 43⋅0 | 11⋅8 | 43⋅8 | 12⋅8 | 0⋅554 | 43⋅4 | 12⋅3 |
| Females | 51⋅0 | 23⋅8 | 47⋅5 | 9⋅7 | 0⋅829 | 48⋅2 | 12⋅5 |
| TAG (mg/dl) | 118⋅0 | 69⋅2 | 129⋅3 | 147⋅4 | 0⋅527 | 123⋅8 | 115⋅6 |
| ALT (IU/l) | 37⋅6 | 50⋅7 | 32⋅3 | 26⋅5 | 0⋅870 | 34⋅9 | 40⋅2 |
| AST (IU/l) | 32⋅7 | 29⋅7 | 32⋅1 | 25⋅2 | 0⋅924 | 32⋅4 | 27⋅4 |
OST, opioid substitution treatment; Hgb, haemoglobin; Hct, haematocrit; FBS, fasting blood sugar; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TAG, triacylglycerol; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
P < 0⋅05 using independent samples t test.
**P < 0⋅05 using Mann–Whitney U test.
No significant difference between the OST and rehabilitation groups when females were excluded from the sample.
Significant difference between the OST and rehabilitation groups when females were excluded from the sample.